In recent years, life sciences companies increasingly have being willing to enter into strategic alliances and joint ventures to develop new or improved products. Baker & Daniels' professionals have coupled their strong corporate transaction experience in the life sciences arena with an understanding of intellectual property, technology and licensing issues to counsel our pharmaceutical, medical device and biotechnology clients on the establishment of these types of strategic alliances and joint ventures.
We serve as corporate counsel to several biotechnology companies developing products targeted at metabolic disorders, infectious diseases, central nervous system conditions and other therapeutic areas. Our professionals have served as corporate counsel for global and national medical companies; advised clients in seed and venture capital investments, mezzanine financing and commercial credit facilities; and have years of experience forming alliances for the development and commercialization of surgical techniques, medical devices, drugs, biologics, diagnostics and research tools. Our clients are among the largest and most successful pharmaceutical and device companies in the world.
We want to see our clients' businesses grow and become successful, thriving enterprises — and we have the experience and skills to help them achieve their goals.
Related Practices